Preclinical mouse models for BRCA1-associated breast cancer
- PMID: 19904273
- PMCID: PMC2778535
- DOI: 10.1038/sj.bjc.6605350
Preclinical mouse models for BRCA1-associated breast cancer
Abstract
A substantial part of all hereditary breast cancer cases is caused by BRCA1 germline mutations. In this review, we will discuss the insights into BRCA1 functions that we obtained from mouse models with conventional and conditional mutations in Brca1. The most advanced models closely resemble human BRCA1-related breast cancer and may therefore be useful for addressing clinically relevant questions.
References
-
- Ben David Y, Chetrit A, Hirsh-Yechezkel G, Friedman E, Beck BD, Beller U, Ben-Baruch G, Fishman A, Levavi H, Lubin F, Menczer J, Piura B, Struewing JP, Modan B (2002) Effect of BRCA mutations on the length of survival in epithelial ovarian tumors. J Clin Oncol 2: 463–466 - PubMed
-
- Brodie SG, Xu X, Qiao W, Li WM, Cao L, Deng CX (2001) Multiple genetic changes are associated with mammary tumorigenesis in Brca1 conditional knockout mice. Oncogene 20: 7514–7523 - PubMed
-
- Byrski T, Gronwald J, Huzarski T, Grzybowska E, Budryk M, Stawicka M, Mierzwa T, Szwiec M, oelig;niowski R, Siolek M, Narod SA, Lubinski J (2008) Response to neo-adjuvant chemotherapy in women with BRCA1-positive breast cancers. Breast Cancer Res Treat 108: 289–296 - PubMed
-
- Byrski T, Huzarski T, Dent R, Gronwald J, Zuziak D, Cybulski C, Kladny J, Gorski B, Lubinski J, Narod SA (2009) Response to neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients. Breast Cancer Res Treat 115: 359–363 - PubMed
-
- Chandler J, Hohenstein P, Swing DA, Tessarollo L, Sharan K (2001) Human BRCA1 gene rescues the embryonic lethality of Brca1 mutant mice. Genesis 29: 72–77 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous